Aims & Scope
Exposure & Visibility
Standards of Editing & Publishing
Editing and Publishing Platform
Position in China
Journal of Integrative Medicine (JIM) is an international peer-reviewed journal sponsored by Shanghai Association of Integrative Medicine, and co-published by Science Press, China and Elsevier. It is a continuation of the Journal of Chinese Integrative Medicine (JCIM), which was established in 2003 and published in Chinese language (phonetic romanization of the Chinese title used by MEDLINE/PubMed: Zhong Xi Yi Jie He Xue Bao; ISSN 1672-1977). In 2013, the journal title was changed as Journal of Integrative Medicine (JIM). Since 2013, JIM has been published in English language bimonthly.
JIM is an interdisciplinary journal focusing on academic research and clinical studies in the field of integrative medicine. Headed by experienced and internationally recognized Editors-in-Chief and supported by a strong, internationally diverse team of editors, JIM looks to establish itself as an outstanding English language journal in its area of focus. We are committed to make JIM an international platform for publishing high-quality papers on complementary and alternative medicine (CAM) and an open forum in which the different professions and international scholarly communities can exchange views, share research and their clinical experience, discuss CAM education, and confer about issues and problems in our various disciplines and in CAM as a whole in order to promote integrative medicine.
We seek to publish high-quality papers on any aspects of integrative medicine, such as acupuncture and traditional Chinese medicine, Ayurveda medicine, herbal medicine, homeopathy, nutrition, chiropractic, mind-body medicine, Taichi, Qigong, meditation, and any other modalities of CAM; our commitment to international scope ensures that research and progress from all regions of the world are widely covered.
Article types include but are not limited to randomized controlled and pragmatic trials, translational and patient-centered effectiveness outcome studies, case series and reports, preclinical and basic science studies, systematic reviews and meta-analyses, papers on methodology and CAM history or education, conference proceedings, editorials, commentaries, short communications, book reviews, and letters to the editor.
JIM is indexed in Web of Science, Science Citation Index Expanded (SCIE), MEDLINE/PubMed, Scopus, ScienceDirect, Embase, Chemical Abstracts, CAB Abstracts, EBSCO, Western Pacific Region Index Medicus (WPRIM), Chinese Science Citation Database (CSCD) and China National Knowledge Infrastructure (CNKI).
JIM is also partnered with TrendMD, using TrendMD service to have links to JIM content displayed on the websites of other users of TrendMD.
These ensure that articles published in JIM have the maximum exposure and visibility to the international scholarly community.
Editor-in-Chief of JIM is Prof. Lixing Lao. The Editorial Board of JIM is composed of 77 members (including Editors-in-Chief, Associate Editors-in-Chief, Advisory Board members and Editorial Board members) from 15 countries.
More information on the Editorial Board.
The Editorial Office of JIM is based at the Shanghai Association of Integrative Medicine, Shanghai, China.
More information on the Editorial Office.
JIM adheres to international standards for format of manuscripts, publication ethics, conflict of interest, and trial registration. It is a member of the Committee on Publication Ethics (COPE), and follows the ICMJE Recommendations and the internationally accepted reporting guidelines.
JIM complies with the publishing standards of Elsevier, Science Press, and the Chinese Government Regulations on periodicals. It was awarded as “Excellent-quality Publishing Journal” by Science Press in 2015, and “Excellent-quality Editing Journal” by Shanghai Municipal Press and Publication Bureau in 2016 and 2018.
Print issue and online issue of JIM are published for the same content. E-edition is published by Elsevier, displayed in the journal home page of Elsevier publication platform – ScienceDirect, and the Editorial Office has its own another website.
In addition to articles published on a subscription basis, JIM also includes open access articles. If an author selects the open access option, the Publisher – Elsevier charges the author a publication fee for gold open access (“the Open Access Fee”) following acceptance of an article for publication in the Journal.
JIM uses ScholarOne Manuscripts submitting and review system, which is used by the editors, reviewers and authors of JIM.
From 2016 to 2019, for four consecutive years, JIM was honored as “the Highest International Impact Academic Journal of China” by Academic Literature Evaluation Research Center of China, which is sponsored by CNKI. Only the Top 5% of the evaluated journals were awarded this honor.
According to the Journal Citation Reports, Impact Factor 2020 for JIM is 3.034, ranking at 9/29 of the journals in the category of Integrative & Complementary Medicine.
According to the Scopus Journal Metrics, CiteScore 2021 for JIM is 6.2 (3-year impact factor), ranking at 11/93 of the journals in the category of Complementary & Alternative Medicine.
Google Scholar h5-index for JIM ranks at the 13th in all journals of Alternative and Traditional Medicine.
Copyright © 2022, Journal of Integrative Medicine Editorial Office, E-edition published by Elsevier (Singapore) Pte Ltd. All rights reserved.
Lixing Lao, Virginia, USA
Frequency: 6 issues per year
Publisher: Science Press, China
Full text is available also online at
- Total Visits: Day Visit: online: